Glaukos' Insider Sales: Diversification, Not Distress, Amidst Strong Growth

Related Articles

Alignment Healthcare's Insider Sales Signal Diversification, Not Distress, Amidst Medicare Advantage Policy Headwinds

1 week ago

Arista Networks' Insider Sales: Diversification Amidst AI Growth Scrutiny

1 day ago

CoreWeave's Billion-Dollar Insider Sales: A Diversification Play Amidst Explosive AI Growth

5 days ago

Procore's Insider Sales: A Planned Exit, Not a Crisis, Amidst Valuation Reset

4 days ago

Category

You may also like

Stock News•2 weeks ago

CoreWeave Insider Sales Look Big, But Should Investors Worry?

CoreWeave shares rose despite insider sales totaling billions, as investors focused on the company's AI-driven growth narrative rather than insider selling activity.

CRWV

Share

Stock News•1 months ago

Blackbaud's CFO Sells Shares

Blackbaud's CFO sold 6,205 shares (~$194,000), reducing his direct holdings by 9% to 62,869 shares.

BLKB

Share

Stock News•1 months ago

Nan Fung Group Sells $4.3 Million in Oculis Shares As Lead Drug Stumbles

Nan Fung Group sold $4.3M in Oculis shares after the lead drug stumbled, signaling insider concern over the clinical-stage biotech's late-stage topical therapies for diabetic and neuro-ophthalmic eye ...

OCS

Share

Stock News•2 months ago

Glaukos Gains on Q1 Earnings Beat & Improved 2026 Revenue Outlook

Glaukos revenue rose 41% in Q1, exceeding analyst estimates as strong performance in glaucoma and corneal segments narrowed the company's net loss. Management also raised its 2026 revenue outlook, cit...

GKOS

Share